Jared Barsky
Examiner (ID: 13656, Phone: (571)272-2795 , Office: P/1628 )
Most Active Art Unit | 1628 |
Art Unit(s) | 1628 |
Total Applications | 964 |
Issued Applications | 443 |
Pending Applications | 93 |
Abandoned Applications | 428 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 9107088
[patent_doc_number] => 20130280220
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-10-24
[patent_title] => 'CHIMERIC ANTIGEN RECEPTOR FOR BISPECIFIC ACTIVATION AND TARGETING OF T LYMPHOCYTES'
[patent_app_type] => utility
[patent_app_number] => 13/788267
[patent_app_country] => US
[patent_app_date] => 2013-03-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 26
[patent_figures_cnt] => 26
[patent_no_of_words] => 24963
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13788267
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/788267 | CHIMERIC ANTIGEN RECEPTOR FOR BISPECIFIC ACTIVATION AND TARGETING OF T LYMPHOCYTES | Mar 6, 2013 | Abandoned |
Array
(
[id] => 9864161
[patent_doc_number] => 20150044180
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-02-12
[patent_title] => 'ISOLATION AND USE OF PLURIPOTENT STEM CELL POPULATION FROM ADULT NEURAL CREST-DERIVED TISSUES'
[patent_app_type] => utility
[patent_app_number] => 14/382287
[patent_app_country] => US
[patent_app_date] => 2013-03-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 22
[patent_no_of_words] => 17465
[patent_no_of_claims] => 56
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14382287
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/382287 | Isolation and use of pluripotent stem cell population from adult neural crest-derived tissues | Feb 28, 2013 | Issued |
Array
(
[id] => 9311625
[patent_doc_number] => 08652842
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-02-18
[patent_title] => 'Humanized immunoglobulin loci'
[patent_app_type] => utility
[patent_app_number] => 13/779585
[patent_app_country] => US
[patent_app_date] => 2013-02-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 49
[patent_figures_cnt] => 22
[patent_no_of_words] => 20509
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 142
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13779585
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/779585 | Humanized immunoglobulin loci | Feb 26, 2013 | Issued |
Array
(
[id] => 12924781
[patent_doc_number] => 09827307
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-11-28
[patent_title] => Use of herpes vectors for tumor therapy
[patent_app_type] => utility
[patent_app_number] => 13/769182
[patent_app_country] => US
[patent_app_date] => 2013-02-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 13
[patent_no_of_words] => 8890
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 127
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13769182
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/769182 | Use of herpes vectors for tumor therapy | Feb 14, 2013 | Issued |
Array
(
[id] => 8891551
[patent_doc_number] => 20130164735
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-06-27
[patent_title] => 'METHOD OF MEASURING HUMAN CYP3A INDUCIBILITY'
[patent_app_type] => utility
[patent_app_number] => 13/754006
[patent_app_country] => US
[patent_app_date] => 2013-01-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 4544
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13754006
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/754006 | METHOD OF MEASURING HUMAN CYP3A INDUCIBILITY | Jan 29, 2013 | Abandoned |
Array
(
[id] => 8855809
[patent_doc_number] => 20130145484
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-06-06
[patent_title] => 'ANTIBODY PRODUCING NON-HUMAN MAMMALS'
[patent_app_type] => utility
[patent_app_number] => 13/750753
[patent_app_country] => US
[patent_app_date] => 2013-01-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 79
[patent_figures_cnt] => 79
[patent_no_of_words] => 26604
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13750753
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/750753 | Antibody producing non-human mammals | Jan 24, 2013 | Issued |
Array
(
[id] => 8927587
[patent_doc_number] => 20130183347
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-07-18
[patent_title] => 'Somatic Transgene Immunization and Related Methods'
[patent_app_type] => utility
[patent_app_number] => 13/736599
[patent_app_country] => US
[patent_app_date] => 2013-01-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 40
[patent_figures_cnt] => 40
[patent_no_of_words] => 34047
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13736599
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/736599 | Somatic Transgene Immunization and Related Methods | Jan 7, 2013 | Abandoned |
Array
(
[id] => 8814575
[patent_doc_number] => 20130115620
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-05-09
[patent_title] => 'Novel Hemopoietin Receptor Protein, NR10'
[patent_app_type] => utility
[patent_app_number] => 13/719926
[patent_app_country] => US
[patent_app_date] => 2012-12-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 23204
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13719926
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/719926 | Novel Hemopoietin Receptor Protein, NR10 | Dec 18, 2012 | Abandoned |
Array
(
[id] => 10939348
[patent_doc_number] => 20140342369
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-11-20
[patent_title] => 'HAPLOID CELLS'
[patent_app_type] => utility
[patent_app_number] => 14/361655
[patent_app_country] => US
[patent_app_date] => 2012-11-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 30917
[patent_no_of_claims] => 41
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14361655
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/361655 | HAPLOID CELLS | Nov 29, 2012 | Abandoned |
Array
(
[id] => 8671541
[patent_doc_number] => 20130046079
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-02-21
[patent_title] => 'MOUSE LAMBDA LIGHT CHAIN LOCUS'
[patent_app_type] => utility
[patent_app_number] => 13/654007
[patent_app_country] => US
[patent_app_date] => 2012-10-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 5725
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13654007
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/654007 | Mouse λ light chain locus | Oct 16, 2012 | Issued |
Array
(
[id] => 9685936
[patent_doc_number] => 20140242701
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-08-28
[patent_title] => 'CHIMERIC ANTIGEN RECEPTOR'
[patent_app_type] => utility
[patent_app_number] => 14/349763
[patent_app_country] => US
[patent_app_date] => 2012-10-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 12077
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14349763
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/349763 | Chimeric antigen receptor | Oct 4, 2012 | Issued |
Array
(
[id] => 9699010
[patent_doc_number] => 20140248695
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-09-04
[patent_title] => 'Viral Vectors Purification System'
[patent_app_type] => utility
[patent_app_number] => 14/349531
[patent_app_country] => US
[patent_app_date] => 2012-10-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 8993
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14349531
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/349531 | Viral Vectors Purification System | Oct 4, 2012 | Abandoned |
Array
(
[id] => 10642592
[patent_doc_number] => 09359449
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-06-07
[patent_title] => 'Light-sensitive ion-passing molecules'
[patent_app_type] => utility
[patent_app_number] => 13/623612
[patent_app_country] => US
[patent_app_date] => 2012-09-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 33
[patent_figures_cnt] => 46
[patent_no_of_words] => 45217
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 213
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13623612
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/623612 | Light-sensitive ion-passing molecules | Sep 19, 2012 | Issued |
Array
(
[id] => 10522736
[patent_doc_number] => 09249234
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-02-02
[patent_title] => 'Light-sensitive ion-passing molecules'
[patent_app_type] => utility
[patent_app_number] => 13/622809
[patent_app_country] => US
[patent_app_date] => 2012-09-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 33
[patent_figures_cnt] => 46
[patent_no_of_words] => 44913
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 62
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13622809
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/622809 | Light-sensitive ion-passing molecules | Sep 18, 2012 | Issued |
Array
(
[id] => 8780102
[patent_doc_number] => 20130102077
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-04-25
[patent_title] => 'ALTERATIONS UTILIZING NANOPARTICLES'
[patent_app_type] => utility
[patent_app_number] => 13/618783
[patent_app_country] => US
[patent_app_date] => 2012-09-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 6686
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13618783
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/618783 | Alterations utilizing nanoparticles | Sep 13, 2012 | Issued |
Array
(
[id] => 9375804
[patent_doc_number] => 08680068
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-03-25
[patent_title] => 'Herpes virus strains'
[patent_app_type] => utility
[patent_app_number] => 13/600711
[patent_app_country] => US
[patent_app_date] => 2012-08-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 5688
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 85
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13600711
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/600711 | Herpes virus strains | Aug 30, 2012 | Issued |
Array
(
[id] => 8884170
[patent_doc_number] => 20130157354
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-06-20
[patent_title] => 'TRANSGENIC NON-HUMAN ANIMALS FOR PRODUCING CHIMERIC ANTIBODIES'
[patent_app_type] => utility
[patent_app_number] => 13/597788
[patent_app_country] => US
[patent_app_date] => 2012-08-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 105
[patent_figures_cnt] => 105
[patent_no_of_words] => 89887
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13597788
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/597788 | TRANSGENIC NON-HUMAN ANIMALS FOR PRODUCING CHIMERIC ANTIBODIES | Aug 28, 2012 | Abandoned |
Array
(
[id] => 9756204
[patent_doc_number] => 20140286905
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-09-25
[patent_title] => 'RECOMBINANT ADENOVIRUS COMPRISING TRANS-SPLICING RIBOZYME AND CANCER-TREATING GENE, AND USE THEREOF'
[patent_app_type] => utility
[patent_app_number] => 14/239543
[patent_app_country] => US
[patent_app_date] => 2012-08-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 9596
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14239543
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/239543 | RECOMBINANT ADENOVIRUS COMPRISING TRANS-SPLICING RIBOZYME AND CANCER-TREATING GENE, AND USE THEREOF | Aug 19, 2012 | Abandoned |
Array
(
[id] => 13233795
[patent_doc_number] => 10130081
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-11-20
[patent_title] => Humanized universal light chain mice
[patent_app_type] => utility
[patent_app_number] => 13/566765
[patent_app_country] => US
[patent_app_date] => 2012-08-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 46
[patent_figures_cnt] => 46
[patent_no_of_words] => 46818
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 180
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13566765
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/566765 | Humanized universal light chain mice | Aug 2, 2012 | Issued |
Array
(
[id] => 8816826
[patent_doc_number] => 20130117871
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-05-09
[patent_title] => 'Human Antibodies Derived from Immunized Xenomice'
[patent_app_type] => utility
[patent_app_number] => 13/561449
[patent_app_country] => US
[patent_app_date] => 2012-07-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 12697
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13561449
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/561449 | Human Antibodies Derived from Immunized Xenomice | Jul 29, 2012 | Abandoned |